» Articles » PMID: 39386266

Coronary Artery Calcification is Prevalent in Systemic Sclerosis and is Associated with Adverse Prognosis

Abstract

Objective: Coronary artery calcification assessed on thoracic computed tomography represents the calcific component of established coronary artery disease, is a biomarker of total atheromatous plaque burden and predicts mortality. Systemic sclerosis is a pro-inflammatory condition, and inflammation is also a driver of coronary artery disease. We assessed coronary artery calcification prevalence, mortality risk and potential clinical impact on primary prevention in a cohort of patients with systemic sclerosis, differentiated by clinical phenotype including the presence of interstitial lung disease and pulmonary arterial hypertension.

Methods: Retrospective analysis of 258 computed tomographies in systemic sclerosis patients from three prospectively maintained clinical and research databases at a single tertiary rheumatology/pulmonary hypertension (PH) service between March 2007 and September 2020 (mean age = 65 ± 12, 14% male). Co-morbidities, statin prescription and all-cause mortality were recorded. Patients were subtyped according to underlying systemic sclerosis complications. Computed tomographies were re-reviewed for coronary artery calcification; severity was graded using a 4-point scale per vessel and summed for total coronary artery calcification score. The impact of reporting coronary artery calcification was assessed against pre-existing statin prescriptions.

Results: Coronary artery calcification was present in 58% (149/258). Coronary artery calcification was more prevalent in systemic sclerosis-pulmonary arterial hypertension than in systemic sclerosis subgroups with interstitial lung disease or without pulmonary arterial hypertension, controlling for age, sex, co-morbidities and smoking status (71%; (13) = 81.4;  < 0.001). The presence and severity of coronary artery calcification were associated with increased risk of mortality independently of age and co-morbidities (hazard ratio = 2.8; 95% confidence interval = 1.2-6.6;  = 0.018). The 'number needed to report' coronary artery calcification presence to potentially impact management was 3.

Conclusions: Coronary artery calcification is common in systemic sclerosis. Coronary artery calcification predicts mortality independently of age and confounding co-morbidities which suggests this finding has clinical relevance and is a potential target for screening and therapeutic intervention.

References
1.
Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic M, Ronda N . Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005; 112(21):3337-47. DOI: 10.1161/CIRCULATIONAHA.104.507996. View

2.
Lee H, Lim S, Park S . Role of Inflammation in Arterial Calcification. Korean Circ J. 2021; 51(2):114-125. PMC: 7853899. DOI: 10.4070/kcj.2020.0517. View

3.
Rubio-Rivas M, Royo C, Simeon C, Corbella X, Fonollosa V . Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum. 2014; 44(2):208-19. DOI: 10.1016/j.semarthrit.2014.05.010. View

4.
Patel J, Pallazola V, Dudum R, Greenland P, McEvoy J, Blumenthal R . Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2021; 6(10):1161-1170. PMC: 8281019. DOI: 10.1001/jamacardio.2021.2321. View

5.
Whitmore K, Zhou Z, Chapman N, Huynh Q, Magnussen C, Sharman J . Impact of Patient Visualization of Cardiovascular Images on Modification of Cardiovascular Risk Factors: Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2023; 16(8):1069-1081. DOI: 10.1016/j.jcmg.2023.03.007. View